Local Institution - 0230

Hangzhou, Zhejiang 310003

0 studies enrolling now · 1 studies all time

What they study most

Advanced Cancer

Studies at this site

• An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer — Completed